Literature DB >> 24041969

Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.

Agustín Ruiz1, Oriol Dols-Icardo, María J Bullido, Pau Pastor, Eloy Rodríguez-Rodríguez, Adolfo López de Munain, Marian M de Pancorbo, Jordi Pérez-Tur, Victoria Alvarez, Anna Antonell, Jesús López-Arrieta, Isabel Hernández, Lluís Tárraga, Mercè Boada, Alberto Lleó, Rafael Blesa, Ana Frank-García, Isabel Sastre, Cristina Razquin, Sara Ortega-Cubero, Elena Lorenzo, Pascual Sánchez-Juan, Onofre Combarros, Fermín Moreno, Ana Gorostidi, Xabier Elcoroaristizabal, Miquel Baquero, Eliecer Coto, Raquel Sánchez-Valle, Jordi Clarimón.   

Abstract

A non-synonymous genetic rare variant, rs75932628-T (p.R47H), in the TREM2 gene has recently been reported to be a strong genetic risk factor for Alzheimer's disease (AD). Also, rare recessive mutations have been associated with frontotemporal dementia (FTD). We aimed to investigate the role of p.R47H variant in AD and FTD through a multi-center study comprising 3172 AD and 682 FTD patients and 2169 healthy controls from Spain. We found that 0.6% of AD patients carried this variant compared to 0.1% of controls (odds ratio [OR] = 4.12, 95% confidence interval [CI] = 1.21-14.00, p = 0.014). A meta-analysis comprising 32,598 subjects from 4 previous studies demonstrated the large effect of the p.R47H variant in AD risk (OR = 4.11, 95% CI = 2.99-5.68, p = 5.27×10(-18)). We did not find an association between p.R47H and age of onset of AD or family history of dementia. Finally, none of the FTD patients harbored this genetic variant. These data strongly support the important role of p.R47H in AD risk, and suggest that this rare genetic variant is not related to FTD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Frontotemporal dementia; Genetic association; Rare variant; TREM2; p.R47H

Mesh:

Substances:

Year:  2013        PMID: 24041969     DOI: 10.1016/j.neurobiolaging.2013.08.011

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  48 in total

Review 1.  TREM2 variants: new keys to decipher Alzheimer disease pathogenesis.

Authors:  Marco Colonna; Yaming Wang
Journal:  Nat Rev Neurosci       Date:  2016-02-25       Impact factor: 34.870

2.  PLD3 in non-familial Alzheimer's disease.

Authors:  Stefanie Heilmann; Dmitriy Drichel; Jordi Clarimon; Victoria Fernández; André Lacour; Holger Wagner; Mathias Thelen; Isabel Hernández; Juan Fortea; Montserrat Alegret; Rafael Blesa; Ana Mauleón; Maitée Rosende Roca; Johannes Kornhuber; Oliver Peters; Reinhard Heun; Lutz Frölich; Michael Hüll; Michael T Heneka; Eckart Rüther; Steffi Riedel-Heller; Martin Scherer; Jens Wiltfang; Frank Jessen; Tim Becker; Lluís Tárraga; Mercè Boada; Wolfgang Maier; Alberto Lleó; Agustin Ruiz; Markus M Nöthen; Alfredo Ramirez
Journal:  Nature       Date:  2015-04-02       Impact factor: 49.962

3.  Reserve and Alzheimer's disease genetic risk: Effects on hospitalization and mortality.

Authors:  Teresa Jenica Filshtein; Willa D Brenowitz; Elizabeth Rose Mayeda; Timothy J Hohman; Stefan Walter; Rich N Jones; Fanny M Elahi; M Maria Glymour
Journal:  Alzheimers Dement       Date:  2019-07       Impact factor: 21.566

4.  TREM2 variants and risk of Alzheimer's disease: a meta-analysis.

Authors:  Yanjun Lu; Wei Liu; Xiong Wang
Journal:  Neurol Sci       Date:  2015-06-03       Impact factor: 3.307

5.  TREM2 regulates microglial cell activation in response to demyelination in vivo.

Authors:  Claudia Cantoni; Bryan Bollman; Danilo Licastro; Mingqiang Xie; Robert Mikesell; Robert Schmidt; Carla M Yuede; Daniela Galimberti; Gunilla Olivecrona; Robyn S Klein; Anne H Cross; Karel Otero; Laura Piccio
Journal:  Acta Neuropathol       Date:  2015-01-29       Impact factor: 17.088

6.  Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.

Authors:  Elkin O Luis; Sara Ortega-Cubero; Isabel Lamet; Cristina Razquin; Carlos Cruchaga; Bruno A Benitez; Elena Lorenzo; Jaione Irigoyen; Maria A Pastor; Pau Pastor
Journal:  Neurobiol Aging       Date:  2014-06-17       Impact factor: 4.673

Review 7.  Microglia-Mediated Neuroprotection, TREM2, and Alzheimer's Disease: Evidence From Optical Imaging.

Authors:  Carlo Condello; Peng Yuan; Jaime Grutzendler
Journal:  Biol Psychiatry       Date:  2017-10-14       Impact factor: 13.382

8.  Genetic Analysis of TREM2 Variants in Tunisian Patients with Alzheimer's Disease.

Authors:  Zied Landoulsi; Mouna Ben Djebara; Imen Kacem; Youssef Sidhom; Rym Kefi; Sonia Abdelhak; Amina Gargouri-Berrechid; Riadh Gouider
Journal:  Med Princ Pract       Date:  2018-05-03       Impact factor: 1.927

9.  The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer's dementia.

Authors:  Panos Roussos; Pavel Katsel; Peter Fam; Weilun Tan; Dushyant P Purohit; Vahram Haroutunian
Journal:  Alzheimers Dement       Date:  2014-12-09       Impact factor: 21.566

10.  TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy.

Authors:  Peng Yuan; Carlo Condello; C Dirk Keene; Yaming Wang; Thomas D Bird; Steven M Paul; Wenjie Luo; Marco Colonna; David Baddeley; Jaime Grutzendler
Journal:  Neuron       Date:  2016-05-18       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.